# Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects

> **NCT01675609** · PHASE2 · COMPLETED · sponsor: **Eye Therapies, LLC** · enrollment: 57 (actual)

## Conditions studied

- Ocular Redness

## Interventions

- **DRUG:** Placebo
- **DRUG:** Brimonidine tartrate 0.025%

## Key facts

- **NCT ID:** NCT01675609
- **Lead sponsor:** Eye Therapies, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-10
- **Final completion:** —
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675609, "Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01675609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*